Linzhen Li

488 total citations
39 papers, 339 citations indexed

About

Linzhen Li is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Linzhen Li has authored 39 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Biomedical Engineering. Recurrent topics in Linzhen Li's work include Catalysis for Biomass Conversion (8 papers), Inflammatory Bowel Disease (8 papers) and Biofuel production and bioconversion (5 papers). Linzhen Li is often cited by papers focused on Catalysis for Biomass Conversion (8 papers), Inflammatory Bowel Disease (8 papers) and Biofuel production and bioconversion (5 papers). Linzhen Li collaborates with scholars based in China, Pakistan and Saudi Arabia. Linzhen Li's co-authors include Liangfang Zhu, Yexin Hu, Changwei Hu, Hongjie Zhang, Qiaobo Ye, Di Wu, Zhen Ye, Yu Hu, Mingquan Wu and Ping Hu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Carbohydrate Polymers.

In The Last Decade

Linzhen Li

35 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linzhen Li China 11 113 72 56 43 35 39 339
Zihan Zhao China 15 188 1.7× 62 0.9× 24 0.4× 33 0.8× 32 0.9× 40 579
Bertrand Rihn France 15 152 1.3× 62 0.9× 18 0.3× 47 1.1× 47 1.3× 44 589
Zheng Gang China 8 83 0.7× 23 0.3× 17 0.3× 11 0.3× 42 1.2× 30 271
Lina Zhang China 12 95 0.8× 33 0.5× 26 0.5× 9 0.2× 28 0.8× 64 443
Zhao Ding China 11 142 1.3× 17 0.2× 12 0.2× 13 0.3× 62 1.8× 40 390
Kanglong Wang China 10 140 1.2× 26 0.4× 26 0.5× 32 0.7× 71 2.0× 23 363
Guichun Wang China 14 178 1.6× 46 0.6× 13 0.2× 8 0.2× 12 0.3× 32 518
Wenbiao Nie China 8 109 1.0× 60 0.8× 86 1.5× 23 0.5× 24 0.7× 10 350
Wenwen Wang China 10 156 1.4× 23 0.3× 20 0.4× 7 0.2× 31 0.9× 18 397
Guohua Xu China 9 153 1.4× 74 1.0× 49 0.9× 39 0.9× 35 1.0× 31 394

Countries citing papers authored by Linzhen Li

Since Specialization
Citations

This map shows the geographic impact of Linzhen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linzhen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linzhen Li more than expected).

Fields of papers citing papers by Linzhen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linzhen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linzhen Li. The network helps show where Linzhen Li may publish in the future.

Co-authorship network of co-authors of Linzhen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Linzhen Li. A scholar is included among the top collaborators of Linzhen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linzhen Li. Linzhen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yu, et al.. (2025). Dahuang-Gancao decoction ameliorates testosterone-induced androgenetic alopecia in mice. Journal of Ethnopharmacology. 341. 119347–119347. 5 indexed citations
2.
Hu, Jiashu, Linzhen Li, Kun Li, et al.. (2025). Edgeworthia gardneri (Wall.) Meisn Mitigates CCL4-induced liver injury in mice by modulating gut microbiota, boosting antioxidant defense, and reducing inflammation. Ecotoxicology and Environmental Safety. 293. 118042–118042.
4.
5.
Li, Linzhen, et al.. (2025). Lymphocyte levels in Crohn’s disease patients in clinical remission are significantly lower than those in healthy people. European journal of medical research. 30(1). 84–84. 1 indexed citations
6.
Ye, Zhen, Yu Hu, Mingquan Wu, et al.. (2024). Molecular targets associated with ulcerative colitis and the benefits of atractylenolides-based therapy. Frontiers in Pharmacology. 15. 1398294–1398294. 6 indexed citations
7.
Li, Linzhen, et al.. (2024). Serum uric acid concentration in acute pancreatitis is significantly higher than healthy population. Scientific Reports. 14(1). 18279–18279. 1 indexed citations
8.
Zheng, Yuan F., et al.. (2024). Application of conjugated polymer nanocomposite materials as biosensors in rehabilitation of ankle joint injuries in martial arts sports. SLAS TECHNOLOGY. 29(6). 100213–100213. 1 indexed citations
9.
Li, Linzhen, Zhiyi Tang, Yutong Wang, et al.. (2024). Multi-omics analysis and the remedial effects of Swertiamarin on hepatic injuries caused by CCl4. Ecotoxicology and Environmental Safety. 282. 116734–116734. 3 indexed citations
11.
Li, Linzhen, Yexin Hu, Hui Li, et al.. (2023). Probing the formation of soluble humins in catalytic dehydration of fructose to 5-hydroxymethylfurfural over HZSM-5 catalyst. Fuel. 344. 128133–128133. 9 indexed citations
12.
Li, Linzhen, Zhiyi Tang, Yi Wu, et al.. (2023). The effect of Abrus cantoniensis Hance on liver damage in mice. Ecotoxicology and Environmental Safety. 266. 115560–115560. 6 indexed citations
13.
Ye, Zhen, Linzhen Li, Yuzheng Li, et al.. (2023). Tou Nong powder obstructs ulcerative colitis through the regulation of NF-κB/NLRP3/Caspase-1/GSDMD inflammasome pyroptotic pathway. Journal of Ethnopharmacology. 317. 116846–116846. 14 indexed citations
14.
Li, Chunlin & Linzhen Li. (2023). Risk factors for diabetic ketoacidosis in acute pancreatitis patients with type 2 diabetes. BMC Gastroenterology. 23(1). 257–257. 4 indexed citations
15.
Chen, Liulin, Yu Hu, Zhen Ye, et al.. (2023). Major Indole Alkaloids in Evodia Rutaecarpa: The Latest Insights and Review of Their Impact on Gastrointestinal Diseases. Biomedicine & Pharmacotherapy. 167. 115495–115495. 10 indexed citations
16.
Li, Yuzheng, Zhen Ye, Haiqing He, et al.. (2022). The application of Tong-fu therapeutic method on ulcerative colitis: A systematic review and meta-analysis for efficacy and safety of rhubarb-based therapy. Frontiers in Pharmacology. 13. 1036593–1036593. 4 indexed citations
17.
Ye, Zhen, Qinfeng Huang, Yu Hu, et al.. (2022). A meritorious integrated medical regimen for hepatic fibrosis and its complications via the systematic review and meta-analysis for Dahuang Zhechong pill-based therapy. Frontiers in Medicine. 9. 920062–920062. 5 indexed citations
18.
Ye, Zhen, Yuzheng Li, Mingquan Wu, et al.. (2022). Renshen Baidu powder protects ulcerative colitis via inhibiting the PI3K/Akt/NF-κB signaling pathway. Frontiers in Pharmacology. 13. 880589–880589. 14 indexed citations
19.
Hu, Yu, Zhen Ye, Linzhen Li, et al.. (2022). Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 13. 844961–844961. 16 indexed citations
20.
Zhang, Huiqin, et al.. (2022). Do overqualified employees hide knowledge? The mediating role of psychological contract breach. Frontiers in Psychology. 13. 842725–842725. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026